What one share of Biohaven holds
Biohaven is a biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. We are advancing our innovative portfolio of therapeutics, leveraging our proven drug development experience and multiple proprietary drug development platforms.
Biohaven’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Profit | −$4.48 |
|---|---|
| Capex (buildings and equipment) | $0.00 |
| Free cash flow | −$3.91 |
| Cash and investments | $1.77 |
| Debt | $1.72 |
| Book value | $0.08 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2020 | — | −$3.01 | $0.03 | −$1.96 | — | $0.43 |
| 2021 | — | −$5.43 | $0.02 | −$3.73 | — | $0.88 |
| 2022 | — | −$12.75 | $0.14 | −$6.79 | — | $7.90 |
| 2023 | — | −$5.73 | $0.04 | −$4.70 | — | $5.28 |
| 2024 | — | −$9.28 | $0.04 | −$6.43 | — | $4.18 |
| 2025 | — | −$6.86 | $0.01 | −$5.67 | — | $0.39 |
Common questions about Biohaven
How much does one share of Biohaven earn?
Over the last 12 months, Biohaven lost $4.48 for each share.
Does Biohaven pay a dividend?
Biohaven didn’t pay a dividend over the last 12 months, according to its SEC filings.
What is Biohaven’s book value per share?
Biohaven’s book value is $0.08 per share: what would be left for each share if it sold everything at the values on its books and paid every debt, as of June 30, 2026.
How much cash and debt does each share of Biohaven have?
Each share of Biohaven has $1.77 of cash and investments and $1.72 of debt, as of June 30, 2026.
What is Biohaven’s free cash flow per share?
−$3.91 per share over the last 12 months. Free cash flow is the cash left over after spending on buildings and equipment.
Has Biohaven bought back shares?
Biohaven’s share count rose about 173% from 2020 to 2025. That dilution means each share owns a smaller slice of the company.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.